Rossmore Private Capital’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Buy
98,416
+11,459
+13% +$289K 0.2% 86
2026
Q1
$2.2M Buy
86,957
+6,675
+8% +$170K 0.19% 88
2025
Q4
$2.05M Buy
80,282
+27,464
+52% +$703K 0.18% 94
2025
Q3
$1.35M Buy
52,818
+11,200
+27% +$284K 0.15% 111
2025
Q2
$1.05M Buy
+41,618
New +$1.03M 0.12% 126

Other funds holding IBDX

Rossmore Private Capital's IBDX Position: Q2 2026 in Review

Rossmore Private Capital increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 13% in Q2 2026, buying an estimated $289K and bringing the position to 98,416 shares worth $2.48M. The position accounts for 0.2% of the portfolio, ranked #86.

Rossmore Private Capital first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. 113 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Rossmore Private Capital held 98,416 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.48M as of Q2 2026.
  • Rossmore Private Capital bought 11,459 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $289K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.2% of Rossmore Private Capital's portfolio in Q2 2026, its #86 holding.
  • Rossmore Private Capital first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 113 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.